Caris Life Sciences, Inc.
CAI
$38.39
-$0.09-0.23%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,057.55% | -- | |||
| Total Receivables | -36.53% | -- | |||
| Inventory | 11.11% | -- | |||
| Prepaid Expenses | 39.01% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -55.67% | -- | |||
| Total Current Assets | 386.66% | -- | |||
|
|
|||||
| Total Current Assets | 386.66% | -- | |||
| Net Property, Plant & Equipment | -0.55% | -- | |||
| Long-term Investments | 0.00% | -- | |||
| Goodwill | 0.00% | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 4.38% | -- | |||
| Total Assets | 227.54% | -- | |||
|
|
|||||
| Total Accounts Payable | 18.58% | -- | |||
| Total Accrued Expenses | -24.51% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -88.83% | -- | |||
| Total Finance Division Other Current Liabilities | -30.32% | -- | |||
| Total Other Current Liabilities | -30.32% | -- | |||
| Total Current Liabilities | -44.52% | -- | |||
|
|
|||||
| Total Current Liabilities | -44.52% | -- | |||
| Long-Term Debt | 17.99% | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 2.47% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -99.71% | -- | |||
| Total Liabilities | -22.19% | -- | |||
|
|
|||||
| Common Stock & APIC | 2,154,500.00% | -- | |||
| Retained Earnings | -2.77% | -- | |||
| Treasury Stock & Other | 2.54% | -- | |||
| Total Common Equity | 117.42% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 117.42% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 228.03% | -- | |||
|
|
|||||